Which of the following antiplatelet drugs is a prodrug?
**Core Concept**
Aspirin is an antiplatelet drug that works by irreversibly inhibiting the enzyme cyclooxygenase (COX), thereby preventing the formation of thromboxane A2, a potent platelet activator. However, aspirin itself is not the active form that inhibits COX; rather, it is its metabolite acetylsalicylic acid.
**Why the Correct Answer is Right**
The correct answer is aspirin because it is a prodrug that requires metabolic conversion to its active form, acetylsalicylic acid, to exert its antiplatelet effects. This metabolic conversion is mediated by the enzyme aspirin acetyltransferase, which converts aspirin to acetylsalicylic acid. Acetylsalicylic acid then covalently binds to the COX enzyme, irreversibly inhibiting its activity and preventing thromboxane A2 production.
**Why Each Wrong Option is Incorrect**
**Option A:** Clopidogrel is an antiplatelet drug, but it is not a prodrug. It works by inhibiting the P2Y12 receptor on platelets, which is involved in platelet activation and aggregation.
**Option B:** Prasugrel is an antiplatelet drug that, like clopidogrel, works by inhibiting the P2Y12 receptor. However, it is not a prodrug.
**Option C:** Ticagrelor is an antiplatelet drug that works by inhibiting the P2Y12 receptor, but it is not a prodrug.
**Clinical Pearl / High-Yield Fact**
The irreversible inhibition of COX by aspirin leads to a prolonged effect that lasts for the lifespan of the platelet, typically around 7-10 days. This is why aspirin is often used for long-term antiplatelet therapy in patients with cardiovascular disease.
**Correct Answer:** A. Aspirin.